Rebecca Henderson
From Wikipedia, the free encyclopedia
 |
This article may require cleanup to meet Wikipedia's quality standards. Please discuss this issue on the talk page or replace this tag with a more specific message. This article has been tagged since April 2006. |
Rebecca Henderson is the Eastman Kodak Professor of management at the MIT Sloan School of Management, and a research fellow at the National Bureau of Economic Research.
Henderson specializes in technology strategy and in the broader strategic problems faced by firms in high technology industries. She has experience working in a variety of industries, including machine tools, semiconductor capital equipment, computers, aerospace and consumer goods, but her current research focuses upon the pharmaceutical and biotechnology industries. She received an undergraduate degree in Mechanical Engineering from MIT in 1981 and a doctorate in Business Economics from Harvard University in 1988. She spent 1981-1983 working for the London office of McKinsey and Company.
Her publications include "Underinvestment and Incompetence as Responses to Radical Innovation: Evidence from the Photolithographic Industry." in the Rand Journal of Economics, and "Architectural Innovation: The Reconfiguration of Existing Product Technologies and The Failure of Established Firms," with Kim Clark, in Administrative Science Quarterly. Her pharmaceutical related publications include "Innovation in the Information Age" in the Harvard Business Review, "Racing to Invest? The Dynamics of Competition in Ethical Pharmaceuticals," in the Journal of Economics and Management Strategy, "Scale, Scope and Spillovers: The Determinants of Research Productivity in Ethical Drug Discovery" in the Rand Journal of Economics, "Measuring Competence? Exploring Firm Heterogeneity in Pharmaceutical Research," in the Strategic Management Journal and "The Evolution of Integrative Competence: A study of cardiovascular drug discovery" in Innovation and Corporate Change.
Professor Henderson sits on the Board of the Whitehead Institute for Biomedical Research at MIT and on the Board of the Linbeck Corporation. She also sits on the editorial boards of Management Science, Administrative Science Quarterly, Research Policy, The Economics of Innovation and New Technology and the Strategy Management Journal. She consults widely: her clients include both members of the Fortune 50 and Internet focused startups. She was recently retained by the Department of Justice as an Expert Witness in connection with the Remedies phase of the Microsoft case, and in 2001 was voted “Teacher of the Year” at the Sloan School.
